Chanda Sanjay 4
4 · AN2 Therapeutics, Inc. · Filed Mar 18, 2024
Insider Transaction Report
Form 4
Chanda Sanjay
Chief Development Officer
Transactions
- Award
Common Stock
2024-03-15+27,500→ 28,235 total - Award
Stock Option (right to buy)
2024-03-15+55,000→ 55,000 totalExercise: $3.00Exp: 2034-03-14→ Common Stock (55,000 underlying)
Footnotes (3)
- [F1]These restricted stock units vest as follows: 1/16th of the shares vests quarterly over four years from January 1, 2024, subject to the Reporting Person's continuous service as of such date.
- [F2]Reflects the adjusted total which includes the purchase of 735 shares under the AN2 Therapeutics, Inc. 2022 Employee Stock Purchase Plan on September 29, 2023.
- [F3]The shares subject to the option vest as follows: 1/48th of the shares vests monthly over four years from January 1, 2024, subject to the Reporting Person's continuous service as of such date.